These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 26847678)

  • 21. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
    Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
    Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma.
    Orth MF; Gerke JS; Knösel T; Altendorf-Hofmann A; Musa J; Alba-Rubio R; Stein S; Hölting TLB; Cidre-Aranaz F; Romero-Pérez L; Dallmayer M; Baldauf MC; Marchetto A; Sannino G; Knott MML; Wehweck F; Ohmura S; Li J; Hakozaki M; Kirchner T; Dandekar T; Butt E; Grünewald TGP
    Int J Cancer; 2019 Feb; 144(4):859-867. PubMed ID: 30267407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-152 down-regulation is associated with MET up-regulation in leiomyosarcoma and undifferentiated pleomorphic sarcoma.
    Pazzaglia L; Novello C; Conti A; Pollino S; Picci P; Benassi MS
    Cell Oncol (Dordr); 2017 Feb; 40(1):77-88. PubMed ID: 27900663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor 1α predicts recurrence in high-grade soft tissue sarcoma of extremities and trunk wall.
    Nyström H; Jönsson M; Werner-Hartman L; Nilbert M; Carneiro A
    J Clin Pathol; 2017 Oct; 70(10):879-885. PubMed ID: 28404817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choice of treatment tactics for the recurrence of soft tissue malignant tumor].
    Korzhikov AV; Lapshin IM; Anfilov SV; Fedosiuk AM; Seriakov AP
    Voen Med Zh; 2005 Nov; 326(11):26-31. PubMed ID: 16404903
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature.
    Maher OM; Khatua S; Mukherjee D; Olar A; Lazar A; Luthra R; Liu D; Wu J; Ketonen L; Zaky W
    J Neurooncol; 2016 Mar; 127(1):155-63. PubMed ID: 26718692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HER2/neu does not correlate with survival in soft tissue sarcoma.
    Sato T; Peiper M; Heinecke A; Zurakowski D; Eisenberger CF; Hosch S; Knoefel WT; Izbicki JR
    Onkologie; 2003 Jun; 26(3):268-71. PubMed ID: 12845212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors and oncological outcomes of 122 head and neck soft tissue sarcoma patients treated at a single institution.
    Park JT; Roh JL; Kim SO; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):248-55. PubMed ID: 25001093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of Relevant Clinicopathologic Variables in Epithelioid Sarcoma: A Multi-Institutional Retrospective Study of 44 Patients.
    Asano N; Yoshida A; Ogura K; Kobayashi E; Susa M; Morioka H; Iwata S; Ishii T; Hiruma T; Chuman H; Kawai A
    Ann Surg Oncol; 2015 Aug; 22(8):2624-32. PubMed ID: 25663591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of microscopic tumor extension in local recurrence of myxofibrosarcoma and undifferentiated pleomorphic sarcoma.
    Song B; Lee K; Lee C; Moon KC
    Pathol Int; 2018 Sep; 68(9):509-516. PubMed ID: 30094896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
    Weitz J; Antonescu CR; Brennan MF
    J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors.
    Niimi R; Matsumine A; Iino T; Nakazora S; Nakamura T; Uchida A; Sudo A
    BMC Cancer; 2013 Jun; 13():309. PubMed ID: 23799912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local recurrence and survival in soft tissue sarcomas: the relation of biopsy.
    Thompson RC; Hartman R; Swanson P; Dusenbury K
    Chir Organi Mov; 1990; 75(1 Suppl):131-3. PubMed ID: 2249508
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prognostic factors in patients with malignant fibrous histiocytoma of the extremities].
    Atalar H; Başarir K; Yildiz Y; Sağlik Y
    Acta Orthop Traumatol Turc; 2007; 41(4):271-6. PubMed ID: 18180555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
    Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
    Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-radiation sarcomas. Clinical outcome of 52 Patients.
    Mavrogenis AF; Pala E; Guerra G; Ruggieri P
    J Surg Oncol; 2012 May; 105(6):570-6. PubMed ID: 22012601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
    Lee AY; Agaram NP; Qin LX; Kuk D; Curtin C; Brennan MF; Singer S
    Ann Surg Oncol; 2016 Mar; 23(3):818-25. PubMed ID: 26759307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significant benefits in survival by the use of surgery combined with radiotherapy for retroperitoneal soft tissue sarcoma.
    Hager S; Makowiec F; Henne K; Hopt UT; Wittel UA
    Radiat Oncol; 2017 Jan; 12(1):29. PubMed ID: 28126006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.